AbbVie (ABBV)

Cost of Revenue

$18.37B

TTM · Period ending: · USD

ABBV logo

ABBV Cost of Revenue

Latest reported$18.37B
ABBV TTM Cost of Revenue ($4.64B → $18.37B)
High-resolution chart · PNG

ABBV cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AbbVie Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
18,365,000,000
18,420,000,000
18,204,000,000
18,048,000,000
16,956,000,000
16,812,000,000
16,904,000,000
18,212,000,000
20,485,000,000
20,523,000,000
20,415,000,000
18,881,000,000
17,418,000,000
17,348,000,000
17,414,000,000
17,564,000,000
16,932,000,000
17,285,000,000
17,446,000,000
17,810,000,000
18,470,000,000
17,658,000,000
15,387,000,000
12,709,000,000
9,579,000,000
7,687,000,000
7,439,000,000
7,455,000,000
7,370,000,000
7,485,000,000
7,718,000,000
7,976,000,000
7,757,000,000
7,351,000,000
7,040,000,000
6,315,000,000
6,203,000,000
6,080,000,000
5,833,000,000
5,753,000,000
5,416,000,000
4,927,000,000
4,500,000,000
4,144,000,000
4,071,000,000
4,268,000,000
4,426,000,000
4,589,000,000
4,587,000,000
4,528,000,000
4,581,000,000
4,564,327,000
4,486,327,000
4,505,327,000
4,508,327,000
4,419,063,000
4,553,744,000
4,588,082,000
4,639,393,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.